The Maximum Tumor Reduction Rate of Sunitinib for Advanced Pancreatic Neuroendocrine Tumor in Single Center Experience
نویسندگان
چکیده
منابع مشابه
Single center experience in pancreatic neuroendocrine tumors
Florian Bösch Seite KKK 6 Abstract
متن کاملBreast metastasis from the pancreatic neuroendocrine tumor origin detected by 99mTc-Octreotate scan
A 50 years old woman with history of pancreatic neuroendocrine tumor diagnosed 2 years ago, which has not been surgically removed,was referred to our department for a 99mTc-Octreotate in order to evaluate the somatostatin receptor status. She was treated with regular sandostatin injections and chemotherapy. Her CT scan which was previously performed confirmed lung, adrenal and hepati...
متن کاملIncidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience
BACKGROUND/AIMS Neuroendocrine tumors (NETs) may originate from heterogeneous neuroendocrine cells. The incidence is increasing worldwide, and World Health Organization (WHO) updated its classification in 2010. We investigated clinical characteristics of gastroenteropancreatic NETs in a single center. METHODS Clinicopathologic characteristics of patients with pathologically confirmed gastroen...
متن کاملCardiac Myxoma, a Rare But Most Common Encountered Cardiac Tumor: A Single Center Experience
Introduction: Cardiac myxoma is a benign and rare tumor, which can present with a grim phenomenon if the presentation is late or the diagnosis and surgery are delayed. The purpose of this study was to share our institutional experience of cardiac myxoma. Material and Methods: This retrospective study was conducted to evaluate patients undergoing procedures at a single tertiary care centre for t...
متن کاملSevere resistant hypoglycemia in a patient with a pancreatic neuroendocrine tumor on sunitinib treatment.
OBJECTIVE Sunitinib is a tyrosine kinase inhibitor used in the therapy of pancreatic neuroendocrine tumors (PNETs), metastatic renal cancer and gastrointestinal stromal tumors. We describe a patient with PNET who presented with severe hypoglycemia following sunitinib administration. CASE REPORT A 64-year old man with known metastatic PNET presented with a history of recurring episodes of seve...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2016
ISSN: 0923-7534
DOI: 10.1093/annonc/mdw521.069